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INTRODUCTION
Behcet’s disease (BD) is a chronic, relapsing, multisystemic
inflammatory disorder of unknown cause, which is mainly
characterized by recurrent aphthous oral ulcers, genital ulcers,
uveitis, and skin lesions (1). A wide spectrum of clinical fea-
tures is observed, including involvement of the ophthalmic,
musculoskeletal, vascular, central nervous, and gastrointesti-
nal systems. Diverse vascular complications, such as deep
vein thrombosis, myocardial infarction, arterial aneurysm,
and arterial thrombus formation have been noted in patients
with BD in about 20% to 35% of cases, predominantly in
male patients and those with venous lesions (2). In general,
BD patients with major vessel involvements have a poor pro-
gnosis.
The histopathological features are mainly characterized
by vasculits, with prominent neutrophil and monocyte infi-
latration in perivascular lesions with or without fibrin depo-
sition in the vessel wall (3). Although the pathogenic mech-
anism of vascular involvement in BD is under investigation,
endothelial cell dysfunction is thought to play an important
role in the development of these lesions (4-7). Endothelial
dysfunction leading to abnormal coagulation or fibrolytic
activity and impaired brachial artery flow-mediated dilata-
tion has been demonstrated in BD. Because flow-mediated
dilatation is endothelium-dependent and is largely controlled
by the release of endothelial nitric oxide (NO), an impairment
in endothelium-dependent flow-mediated dilatation suggests
a decreased endothelial NO activity (8). This lack of activity
may contribute to the vascular lesions often seen in BD. In
addition, endothelial NO has been found to directly regulate
large artery stiffness in vivo (9, 10). 
The development of atherosclerotic changes in the vessel
wall is initiated by perturbations in endothelial function,
reflecting a functional change before the presence of morpho-
logic changes. Although a variety of methods have been devel-
oped to evaluate endothelial function, non-invasive high-res-
olution B-mode ultrasonography is typically used. Arterial
intima-media thickness (IMT) is a relatively sensitive marker
of early atherosclerotic vessel wall changes, especially in the
common carotid artery (11, 12). Arterial stiffness is another
parameter which predicts cardiovascular risk that has been
found to reflect the functional properties of arteries (12). 
Acute systemic inflammation and chronic systemic vasculi-
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Intima-media Thickness and Arterial Stiffness of Carotid Artery in
Korean Patients with Behcet’ s Disease 
Behcet’s disease (BD) is a systemic vasculitis involving diverse sizes of arteries
and veins. We performed this study to evaluate the vascular changes by assess-
ment of the arterial stiffness and intima-media thickness (IMT) of carotid artery in
Korean patients with BD. Forty-one patients with BD and age-, and sex-matched
53 healthy subjects were recruited in this study. Carotid arterial stiffness and IMT
were assessed by using high-resolution B-mode ultrasonography. Arterial stiffness
parameters such as carotid arterial distensibility coefficient, stiffness index, and in-
cremental elastic modulus (Einc) were significantly increased in BD patients compared
with those in healthy subjects, but not in IMT. Positive relationship was noted bet-
ween age and IMT, whereas age of onset was significantly associated with arterial
stiffness in BD. This finding suggests impaired endothelial function before visible
structural changes of arterial wall in BD. Age and age of onset may be an indepen-
dent risk factor for carotid IMT and arterial stiffness, respectively. Further studies in
more large populations are required to confirm our results.
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tis are noted as being associated with endothelial dysfunction
(13). Moreover, inflammation is known to be an important
risk factor for future cardiovascular events (14). These find-
ings have led to the hypothesis that BD-associated acute and
chronic inflammatory processes may cause endothelial dys-
function, leading to subsequent increases in IMT and arteri-
al stiffness that are closely related to the clinical course of BD
patients. Because geographic variations in clinical features
including vascular lesions are significant, information has
been limited regarding IMT and arterial stiffness in BD pati-
ents from different ethnic groups. In this study, we investi-
gated carotid IMT and arterial stiffness in Korean patients
with BD. We then assessed whether these predictive mark-
ers were affected by clinical parameters of BD.
MATERIALS AND METHODS
Subjects 
This study included 41 patients with BD who fulfilled the
International Study Group (ISG) criteria (15), along with 53
healthy controls matched to the patients for age, sex, blood
pressure, heart rate, height, and total cholesterol and glucose
levels. The frequency of smokers, if any, was also taken into
account. Subjects with hypertension, diabetes mellitus, hyper-
lipidemia (total cholesterol <200 mg/dL), or a previous his-
tory of coronary artery disease or myocardial infarction were
excluded. Hypertension was defined as systolic blood pres-
sure (SBP) ≥140 mmHg, diastolic blood pressure (DBP)
≥90 mmHg, or the current use of antihypertensive medica-
tions for diagnosed hypertension. The age of onset was defined
as the time at which the patients had met the ISG criteria.
At examination, the presence of two or more of the follow-
ing Behcet’s clinical features was considered as active disease:
oral ulceration, genital ulceration, skin lesions, ocular lesions,
active major vessel disease, and active major organ involve-
ment including active gastrointestinal or neurological lesions.
During the course of the disease, the presence of one or more
of the following clinical features defined severe disease (16):
posterior uveitis or retinal vasculitis, gastrointestinal ulcera-
tions with bleeding or perforation, major organ involvement,
and major vessel involvement. In addition, BD patients with
venous or arterial occlusive diseases or arterial aneurysm were
considered as having vascular lesions; however, those with
superficial thrombophlebitis were not considered as such.
The duration of the disease in the BD group was calculated
from the time from which the ISG criteria were fulfilled to
the time of examination. 
Using standard laboratory methods, the levels of total cho-
lesterol and glucose were measured with fasting blood sam-
ples from all subjects. The study was approved by the Hos-
pital Ethics Committee, and informed and written consent
was obtained from each subject.
Ultrasound measurement 
All subjects were asked to refrain from caffeine, alcohol,
and smoking for 12 hr prior to the measurement. Ultrasound
measurement of the common carotid artery was performed
with an 8 MHz linear array transducer (Sequoia 512, Acu-
son, Mountain View, CA, U.S.A.) after resting in the supine
position for 15 min. All measurements were performed by
the same trained sonographer while in the supine position
with the head slightly turned contralateral to the side being
examined. The right and left CCA were scanned first in a
transverse plane and were then scanned longitudinally. For
the measurement of IMT of the common carotid artery, two
images of the right CCA and two images of the left CCA from
the bifurcation of the carotid artery were scanned at the peak
of the R wave on the electrocardiogram (ECG) and were stored
as digital images. For the measurement of the carotid systolic
and diastolic diameters, B-mode images of three consecutive
heart beats were recorded. After ultrasound examination,
brachial blood pressure was measured from the left upper
arm in a supine position using a semiautomatic device with
oscillometric sensors.
Measurement of carotid IMT
Measurement of IMT was performed by computer with
automatic IMT measurement software (M’Ath
�-Std
ⓒ, Metris,
Argenteuil, France) (17). The IMT was measured 2 cm prox-
imal to the carotid bifurcation along at least 1 cm of axial
length, and was measured as the distance between the lumen-
intima interface and the media-adventitia interface using an
automated edge detection algorithm. Measurements with a
quality index ≥0.5 were used in the analysis. For analysis,
the mean of the right and left CCA IMTs was used.
Measurement of arterial wall elastic properties
Systolic diameters were measured at the maximal diameter
of the CCA, and diastolic diameters were measured at the
peak of the R wave on the ECG. Measured diameters were
averaged and were used for the calculation.
Functional arterial wall properties were assessed by disten-
sibility coefficient (DC), stiffness index ( ), and incremental
elastic modulus (Einc) (18, 19). Carotid arterial DC,  , and
Einc were calculated as follows:
Distensibility coefficient (DC, kPa-1×10-3)=2 ( D/DD)/
(P ×0.133/1000)
=ln (SBP/DBP)/( D/DD)
Einc (kPa×103)=3 (1+LCSA/IMCSA)/DC 
where  D=the difference between the systolic and dias-
tolic diameters, DD=end-diastolic diameter,  P=pulse pres-
sure (mmHg), SBP=systolic blood pressure, and DBP=dias-
tolic blood pressure. LCSA (lumen cross sectional area) and
IMCSA (intima-media cross sectional area) were calculated asCarotid Arterial Stiffness in Behcet’s Disease 389
LCSA= DD2/4 and IMCSA= (DD/2+IMT)2- (DD/2)2.
Statistical analysis
Differences in non-continuous or continuous variables bet-
ween groups were compared using the chi-square test or the
independent t-test when indicated. Bivariate correlations bet-
ween two continuous variables were evaluated using the Pear-
son correlation coefficient when indicated. Multiple regres-
sion analysis was performed to exclude confounding effects
of clinical variables of BD and other risk factors on carotid
IMT and arterial stiffness. p values less than 0.05 were con-
sidered statistically significant. The data were analyzed using
the SPSS statistical package program version 11.5 for Win-
dows (SPSS Inc., Chicago, IL, U.S.A.).
RESULTS
The clinical characteristics of the 41 patients with BD en-
rolled in this study are summarized in Table 1.
Table 2 shows the demographic features and laboratory
findings for each group. No differences between patients with
BD and controls were found in age, sex ratio, or other poten-
tial parameters that affect arterial stiffness and IMT, such as
weight, height, smoking, heart rate, systolic and diastolic
blood pressure, pulse pressure, plasma glucose, and total cho-
lesterol levels.
There were no significant differences in common carotid
artery IMT values between patients with BD and control
subjects, respectively (0.52±0.09 vs. 0.52±0.06, p=0.811)
(Table 3). Carotid plague and aneurysm were not detected
in BD patients or control subjects. We identified significant
differences in all three arterial stiffness parameters between
BD patients and control subjects, including DC (23.10±9.5
vs. 27.90±10.14, p=0.021), (3.26±0.45 vs. 3.04±0.32,
p=0.007), and Einc (0.64±0.33 vs. 0.49±0.16, p=0.008)
(Table 3). 
No associations between clinical, demographic, or labora-
tory parameters or carotid IMT were identified in BD patients.
However, linear regression analysis showed that age and age
*Immunosuppressants included azathioprine, cyclosporine, and inflix-
imab. Values are mean±SD unless otherwise indicated.
Behcet’s disease, n=41
Onset age of disease, yr (range) 31.1±7.5 (17-46)
Disease duration, months (range) 78.1±57.4 (9-228)
HLA-B51 positivity, no. (%) 15 (36.6)
Clinical manifestations, no. (%)
Oral ulcerations  41 (100.0)
Genital ulcerations 26 (63.4)
Erythema nodosum-like lesions 16 (39.0)
Papulopustular lesions 34 (82.9)
Ocular lesions 11 (26.8)
Positive pathergy reaction 20 (48.8)
Gastrointestinal ulcerations 5 (12.2)
Peripheral arthritis 15 (36.6)
Vascular lesions 4 (9.8)
Central nervous system lesions 1 (2.4)
Active lesions 11 (26.8)
Severe lesions 13 (31.7)
Prednisone, no. (%)   28 (68.3)
Mean cumulative dose, mg (range) 716.9±764.0 (0-2680)
Immunosuppressant*, no (%) 11 (26.8)
Table 1. Clinical features of patients with BD
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic
blood pressure; PP, pulse pressure. Values are mean±SD unless oth-
erwise indicated.
Behcet’s disease 
n=41
Control subjects 
n=53
p
Age (yr) 37.6±7.9 37.1±7.2 0.752
Male, no. (%) 20 (48.8) 26 (49.1) 0.979
Weight (kg) 59.3±8.0 61.0±12.1 0.425
Height (cm) 164.1±7.6 164.7±7.8 0.694
BMI (kg/m
2) 22.1±2.7 22.3±2.9 0.658
Smoking, no. (%) 5 (12.2) 5 (9.4) 0.667
Heart rate (no./min) 65.6±7.8 64.9±9.4 0.700
SBP (mmHg) 117.8±11.1 114.4±9.3 0.110
DBP (mmHg) 73.7±9.2 70.7±7.6 0.080
PP (mmHg) 44.1±6.7 44.6±5.3 0.700
Plasma glucose (mg/dL) 85.0±7.9 84.6±8.7 0.841
Total cholesterol (mg/dL) 162.3±32.2 167.3±30.0 0.437
Table 2. Demographic and laboratory characteristics of patients
with BD and control subjects
CCA, common carotid artery; IMT, intima-media thickness; DC, disten-
sibility coefficient;  , stiffness index; Einc, incremental elastic modulus.
Values are mean±SD.
Behcet’s disease 
n=41
Control subjects 
n=53
p
CCA IMT (mm) 0.52±0.09 0.52±0.06 0.811
DC (10
-3×kPa
-1) 23.10±9.5 27.90±10.14 0.021
3.26±0.45 3.04±0.32 0.007
Einc (10
3×kPa) 0.64±0.33 0.49±0.16 0.008
Table 3. Arterial wall measurements of CCA in patients with BD
and control subjects
CCA, common carotid artery; IMT, intima-media thickness; DC, disten-
sibility coefficient;  , stiffness index; Einc, incremental elastic modulus.
Values are mean±SD.
Peripheral 
arthritis (+)
n=15
Peripheral
arthritis (-)
n=26
p
CCA IMT (mm) 0.52±0.10 0.53±0.09 0.843
DC (10
-3×kPa
-1) 17.79±6.26 26.17±9.82 0.002
3.49±0.37 3.13±0.44 0.010
Einc (10
3×kPa) 0.82±0.38 0.54±0.25 0.007
Table 4. Arterial wall measurements of CCA according to the
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of onset were positively associated with increased IMT (r=
0.488, p=0.001 and r=0.328, p=0.036, respectively). The
relationships between arterial stiffness indexes and clinical,
demographic, and laboratory parameters from BD patients
were analyzed using Pearson correlation analysis or t-test where
indicated. BD with peripheral arthritis was significantly prone
to increased arterial stiffness compared with those without
peripheral arthritis (Table 4). Patients with peripheral arthri-
tis exhibited a lower DC and higher  and Einc values than
those without peripheral arthritis. In addition, a positive rela-
tionship between age of onset and arterial stiffness indices
including DC,  and Einc was also noted in linear regression
analysis (r=0.484, p=0.001, r=0.537, p<0.001, and r=0.487,
p=0.002, respectively). 
Multiple regression analysis for arterial stiffness indexes
was used to adjust for potential confounding influences of
age, sex, age of onset, and peripheral arthritis among the clin-
ical features of BD. Age of onset of all arterial stiffness mea-
sures (DC,  , and Einc) had statistical significance (p=0.004,
p=0,002, and p=0.006, respectively), as did in the study for
carotid IMT (p=0.021) (Table 5).
DISCUSSION
Although the exact pathogenesis of BD remains unclear,
small vessel vasculitis accounts for a considerable portion of
the pathogenic processes in BD. In addition, large venous or
arterial lesions can occur in up to one third of patients with
BD (1). Despite uncertainty in the pathogenic mechanism
of vascular lesions in BD, vascular endothelial dysfunction
has been recognized in BD and is thought to play an impor-
tant role in the vascular lesions (6, 7, 20, 21). Structural and
functional features of the vascular system have also become
an important issue in BD. In the present study, we measured
the carotid IMT and rterial stiffness by means of noninvasive
high resolution ultrasonography. 
Previous ultrasonographic data for carotid IMT and/or arte-
rial stiffness in Turkish study groups showed increased IMT
and arterial stiffness in BD patients compared to controls
(21, 22). Our study showed that the carotid IMT value in
BD patients was not different from that in control subjects.
However, arterial stiffness in BD patients was significantly
higher than in control subjects. Several explanations for the
lack of a difference in carotid IMT between the two groups can
be considened. First, the general characteristics of patients
enrolled in this study seem to be different from those of pre-
vious studies. In previous Turkish population studies, a dif-
ference in disease duration or age might influence the results
between the studies (21, 22). Second, on the basis that arte-
rial stiffness may be the first or an early manifestation of struc-
tural and functional vascular changes before the appearance
of increased carotid IMT, there may be a certain potential of
increased carotid IMT in BD patients compared with con-
trols. Third, a multicenter epidemiologic study demonstrat-
ed that the pattern of clinical features in the Korean BD pop-
ulation were partially different from those in Middle East and
Mediterranean regions. Severe manifestations, especially in
vascular involvement and neurologic symptoms, appeared
less frequently in Korean BD patients (23). We suppose that
disease activity or severity in BD may affect the vascular wall
changes, although a definite association has not been deter-
mined. 
With respect to clinical features related with carotid arte-
rial IMT, Alan et al. described that only traditional cardio-
vascular risk factors including SBP, DBP, and pulse pressure
were identified as potential contributing factors for vascular
changes such as carotid IMT in BD without observing unique
risk factors associated with the disease alone (21). On the other
hand, a Turkish study exhibited a weak positive association
between common carotid IMT and disease duration (22). Our
study identified that the carotid IMT level was related with
patients’ age, but not the duration of the disease.
A Turkish population study showed that SBP may be a
risk factor related to arterial stiffness (21). In an arterial stiff-
ness study using pulse wave velocity in Korean BD patients,
Chang et al. demonstrated that age and mean arterial pres-
sure may be independent risk factors for increased pulse wave
velocity in BD (24). However, an association between increased
arterial stiffness and age of disease onset was found in this
study by ultrasonography. Although the presence of periph-
eral arthritis in BD showed an association with all arterial
stiffness indices in univariate analysis, the statistical signifi-
cance of peripheral arthritis was lost in multiple regression
Co-factors
Arterial stiffness
DC
Beta p
Carotid IMT
Beta p Beta p
Einc
Beta p
Age 0.585 0.021 0.456 0.051 -0.414 0.074 -0.457 0.053
Sex 0.126 0.398 -0.195 0.165 0.139 0.318 0.214 0.133
Onset age of disease -0.164 0.492 -0.710 0.004 0.768 0.002 0.695 0.006
Peripheral arthritis* - - -0.232 0.126 0.168 0.264 0.223 0.146
Table 5. Multiple regression analysis for co-factors that affect carotid IMT and arterial stiffness in BD
CCA, common carotid artery; IMT, intima-media thickness; DC, distensibility coefficient;  , stiffness index; Einc, incremental elastic modulus. *Periph-
eral arthritis is only used as a co-factor in arterial stiffness analysis.analysis. 
In addition, no difference of systolic and diastolic diameters
of CCA was identified between BD patients and controls in
this study (data not shown). This finding may be due to sev-
eral factors. First, the prevalence of vascular involvements,
especially artery, in Korean BD seemed to be low, although
the prevalence of these in BD was reviewed between 27.7 and
60.0% in western populations (25). Second, the prevalence
of pulmonary or femoral arterial involvement was more pre-
dominant compared with carotid arterial involvement (26).
Third, our data have limitations in their interpretation, since
this study was performed in a small population.
A definite influence of characteristics of laboratory findings
or serologic markers from BD on abnormalities in carotid
IMT and arterial stiffness has not yet been determined, even
though a great variety of potential factors including homo-
cysteine, von Willebrand factor, and tissue plasminogen acti-
vator inhibitor may play important roles in the pathogene-
sis of endothelial dysfunction in BD (4, 5). Further investi-
gation for a predictive laboratory marker related with vascu-
lar lesions is still required.
We did not perform evaluation of the involvement of other
major arteries such as aorta, femoral artery, innominate artery,
and brachial artery in this study. Carotid IMT has been shown
to be associated with the extent of atherosclerosis in the aorta
and coronary arteries (11, 12, 27, 28). However, carotid IMT
of patients with BD in this study was not different from that
of the control group. In addition, no carotid plaque was noted.
These findings in this study suggest that the possibility of
identifying advanced atherosclerotic lesions in other proxi-
mal or major arteries might not be high. 
In conclusion, the present study demonstrated that patients
with BD have significantly increased arterial stiffness com-
pared to control subjects. However, this was not the case for
carotid IMT, suggesting impaired endothelial function of
carotid artery. Age was an independent significant factor asso-
ciated with increased carotid IMT, whereas onset age was con-
sidered a risk factor for arterial stiffness in BD. Longitudinal
studies in a large population are required to determine the
prognostic implications of increased carotid arterial stiffness
in BD. 
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